Renal Cell Carcinoma
Latest Publications

TOTAL DOCUMENTS

26
(FIVE YEARS 0)

H-INDEX

1
(FIVE YEARS 0)

Published By Springer New York

9781493916214, 9781493916221
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

The Role of Advocacy in Renal Cell Carcinoma

2014 ◽  
pp. 569-599
Author(s):  
William P. Bro ◽  
Paul Larson
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell

Development and Incorporation of Biomarkers in RCC Therapeutics

2014 ◽  
pp. 527-539
Author(s):  
Sumanta K. Pal ◽  
Robert A. Figlin

Side Effects of Targeted Therapy

2014 ◽  
pp. 377-416
Author(s):  
Luis León ◽  
Luis Miguel Antón-Aparicio ◽  
Emilio Esteban-González ◽  
Martin Lázaro-Quintela ◽  
Sergio Vázquez-Éstevez
Keyword(s):  
Targeted Therapy ◽  
Side Effects

Genetic Heterogeneity in Renal Cell Carcinoma: Clinical Implications?

2014 ◽  
pp. 167-176
Author(s):  
Susan A. J. Vaziri ◽  
Mahrukh K. Ganapathi ◽  
Ram N. Ganapathi
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Genetic Heterogeneity ◽  
Renal Cell ◽  
Clinical Implications

Carbonic Anhydrase IX and Monoclonal Antibody G250: Relevance as a Clinical and Biologic Target in Renal Cell Carcinoma

2014 ◽  
pp. 263-284
Author(s):  
Egbert Oosterwijk ◽  
Otto C. Boerman ◽  
Jeannette C. Oosterwijk-Wakka ◽  
Wim J. Oyen ◽  
Peter F. A. Mulders
Keyword(s):  
Renal Cell Carcinoma ◽  
Monoclonal Antibody ◽  
Carbonic Anhydrase ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Carbonic Anhydrase Ix

PI3-kinase, Akt, and mTOR Inhibitors in RCC

2014 ◽  
pp. 253-262
Author(s):  
Daniel C. Cho ◽  
James W. Mier
Keyword(s):  
Mtor Inhibitors ◽  
Pi3 Kinase
Load More ...
Sign in / Sign up

Export Citation Format

Share Document